Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Cost-effectiveness of tenofovi...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Cost-effectiveness of tenofovir alafenamide and entecavir in chronic hepatitis B in Saudi Arabia

Cost-effectiveness of tenofovir alafenamide and entecavir in chronic hepatitis B in Saudi Arabia

Bibliographic Details
Main Author: Ahmed Al-Jedai
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-01-01
Series:The Saudi Journal of Gastroenterology
Online Access:http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2024;volume=30;issue=1;spage=1;epage=3;aulast=Al-Jedai
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2024;volume=30;issue=1;spage=1;epage=3;aulast=Al-Jedai

Similar Items

  • Cost–effectiveness of switching from tenofovir disoproxil fumarate to tenofovir alafenamide versus entecavir for chronic hepatitis B patients in Greece
    by: Emmanouil Sinakos, et al.
    Published: (2024-02-01)
  • Sequential therapy from entecavir to tenofovir alafenamide versus continuous entecavir monotherapy for patients with chronic hepatitis B
    by: Norio Itokawa, et al.
    Published: (2021-01-01)
  • Chronic Hepatitis B Relapse Rates after Cessation of Tenofovir Alafenamide and Entecavir Therapy
    by: Chih-Wen Huang, et al.
    Published: (2023-03-01)
  • Observational pilot study of switching from entecavir to tenofovir alafenamide in patients with chronic hepatitis B
    by: Takuya Matsubara, et al.
    Published: (2025-01-01)
  • Switching from entecavir to tenofovir alafenamide for maintaining complete virological response in chronic hepatitis B
    by: Shun Ishido, et al.
    Published: (2023-08-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs